UChicagoCancerCenter· @UCCancerCenter · X·· 2026-04-21Score60
Body · original
At #AACR26, Yijia Sun presents validation data supporting performance of recently developed PRS. Importantly, a new streamlined 162-SNP TNBC PRS demonstrate consistent, cost-efficient potential that can advance more equitable and precise risk assessment.
@UChicagoPHS
Heat 4 · 2 likes · 0 replies · 2 reposts
Source: UChicagoCancerCenter · x.com
